bopindolol has been researched along with aldosterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, FW; Bolli, P; Bühler, FR; Burckhardt, D; Meyer, B; Müller, FB | 1 |
| Modan, M; Rosenfeld, JB; Shohat, J | 1 |
| Boomsma, F; Derkx, FH; Man in 't Veld, AJ; Mulder, P; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ | 1 |
1 trial(s) available for bopindolol and aldosterone
| Article | Year |
|---|---|
The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
Topics: Adrenergic beta-Antagonists; Aldosterone; Cardiac Output; Clinical Trials as Topic; Epinephrine; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolol; Renin; Research Design; Time Factors | 1987 |
2 other study(ies) available for bopindolol and aldosterone
| Article | Year |
|---|---|
Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Female; Heart Rate; Humans; Male; Middle Aged; Nervous System Diseases; Pindolol; Receptors, Adrenergic, beta; Renin; Substance Withdrawal Syndrome | 1986 |
Bopindolol: long-term effects on blood pressure, renal function, plasma renin activity, and plasma aldosterone in mild-to-moderate essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Blood Pressure; Electrolytes; Female; Heart Rate; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Pindolol; Renin | 1989 |